Related Experiment Video
Updated: Aug 12, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
An evolving perspective on novel modified release drug delivery systems for inhalational therapy
Tanvirul Hye1, Sakib M Moinuddin2,3, Tanoy Sarkar2,3
1Oakland University William Beaumont School of Medicine, 586 Pioneer Dr, 48309, Rochester, MI, USA.
Inhaled modified release formulations offer potential for reduced dosing frequency in respiratory diseases. This review explores advanced strategies and challenges for developing effective inhaled drug delivery systems.
Area of Science:
- Pulmonary drug delivery
- Respiratory medicine
- Formulation science
Background:
- Inhaled drugs primarily treat respiratory disorders like asthma, COPD, and pulmonary hypertension.
- Targeted, modified, or controlled release inhalation formulations are crucial for better patient compliance and therapeutic results.
Approach:
- This review examines factors influencing inhalable modified release formulations.
- It covers various strategies: dissolution rate-controlled systems, drug complexes, site-specific delivery, drug-polymer conjugates, matrix systems, lipid particles, nanosystems, and mucociliary clearance bypass.
Key Points:
- Modified release inhaled formulations can decrease dosing frequency by prolonging lung residence time.
- Current commercialization of these advanced drug delivery systems is limited and underdeveloped.
- The review details the state-of-the-art, development avenues, and translational challenges for inhaled controlled release formulations.
Conclusions:
- Developing modified release inhaled formulations requires addressing formulation strategies and overcoming translational hurdles.
- Further research into novel technologies is essential for advancing inhaled drug delivery for respiratory conditions.
Related Concept Videos
Inhaled Medications
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhalational Anesthetics: Overview
Drug Delivery: Enteral Route

